{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:21:12Z","timestamp":1776374472467,"version":"3.51.2"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41433-024-02940-6","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T10:02:43Z","timestamp":1707300163000},"page":"1518-1528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prophylaxis against intraocular pressure spikes following uncomplicated phacoemulsification: a systematic-review and meta-analysis"],"prefix":"10.1038","volume":"38","author":[{"given":"Raageen","family":"Kanjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-5968","authenticated-orcid":false,"given":"Marko M.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-3478","authenticated-orcid":false,"given":"Ali","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy M. L.","family":"Hutnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqbal Ike K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hady","family":"Saheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"2940_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ophtha.2014.07.047","volume":"122","author":"M Lundstrom","year":"2015","unstructured":"Lundstrom M, Goh PP, Henry Y, Salowi MA, Barry P, Manning S, et al. The changing pattern of cataract surgery indications: a 5-year study of 2 cataract surgery databases. Ophthalmology. 2015;122:31\u20138.","journal-title":"Ophthalmology."},{"key":"2940_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jcrs.2012.11.026","volume":"39","author":"M Lundstrom","year":"2013","unstructured":"Lundstrom M, Barry P, Henry Y, Rosen P, Stenevi U. Visual outcome of cataract surgery; study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery. J Cataract Refract Surg. 2013;39:673\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/eye.2015.3","volume":"29","author":"AC Day","year":"2015","unstructured":"Day AC, Donachie PH, Sparrow JM, Johnston RL. Royal College of Ophthalmologists\u2019 National Ophthalmology D. The Royal College of Ophthalmologists\u2019 National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye. 2015;29:552\u201360.","journal-title":"Eye"},{"key":"2940_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0886-3350(01)00994-4","volume":"28","author":"II Ahmed","year":"2002","unstructured":"Ahmed II, Kranemann C, Chipman M, Malam F. Revisiting early postoperative follow-up after phacoemulsification. J Cataract Refract Surg. 2002;28:100\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0886-3350(02)01891-6","volume":"29","author":"GD Hildebrand","year":"2003","unstructured":"Hildebrand GD, Wickremasinghe SS, Tranos PG, Harris ML, Little BC. Efficacy of anterior chamber decompression in controlling early intraocular pressure spikes after uneventful phacoemulsification. J Cataract Refract Surg. 2003;29:1087\u201392.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ophtha.2006.08.048","volume":"114","author":"G Rainer","year":"2007","unstructured":"Rainer G, Schmid KE, Findl O, Sacu S, Kiss B, Heinzl H, et al. Natural course of intraocular pressure after cataract surgery with sodium hyaluronate 1% versus hydroxypropylmethylcellulose 2%. Ophthalmology. 2007;114:1089\u201393.","journal-title":"Ophthalmology"},{"key":"2940_CR7","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.ophtha.2005.05.011","volume":"112","author":"G Rainer","year":"2005","unstructured":"Rainer G, Menapace R, Schmid KE, Sacu S, Kiss B, Heinze G, et al. Natural course of intraocular pressure after cataract surgery with sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat). Ophthalmology. 2005;112:1714\u20138.","journal-title":"Ophthalmology"},{"key":"2940_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0886-3350(96)80199-4","volume":"22","author":"JC Henry","year":"1996","unstructured":"Henry JC, Olander K. Comparison of the effect of four viscoelastic agents on early postoperative intraocular pressure. J Cataract Refract Surg. 1996;22:960\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/bjo.69.8.572","volume":"69","author":"MS Passo","year":"1985","unstructured":"Passo MS, Ernest JT, Goldstick TK. Hyaluronate increases intraocular pressure when used in cataract extraction. Br J Ophthalmol. 1985;69:572\u20135.","journal-title":"Br J Ophthalmol"},{"key":"2940_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0886-3350(00)00568-X","volume":"27","author":"MP Holzer","year":"2001","unstructured":"Holzer MP, Tetz MR, Auffarth GU, Welt R, Volcker HE. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg. 2001;27:213\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1442-9071.2000.00340.x","volume":"28","author":"G Whitehouse","year":"2000","unstructured":"Whitehouse G. Brimonidine and postoperative pressure spikes in cataract surgery. Clin Exp Ophthalmol. 2000;28:364\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"2940_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S0886-3350(01)00790-8","volume":"27","author":"G Rainer","year":"2001","unstructured":"Rainer G, Menapace R, Findl O, Petternel V, Kiss B, Georgopoulos M. Effect of topical brimonidine on intraocular pressure after small incision cataract surgery. J Cataract Refract Surg. 2001;27:1227\u201331.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR13","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.jcrs.2003.08.029","volume":"29","author":"JM Katsimpris","year":"2003","unstructured":"Katsimpris JM, Siganos D, Konstas AG, Kozobolis V, Georgiadis N. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification. J Cataract Refract Surg. 2003;29:2288\u201394.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/aos.14092","volume":"97","author":"JL Holm","year":"2019","unstructured":"Holm JL, Bach-Holm D, Holm LM, Vestergaard AH. Prophylactic treatment of intraocular pressure elevation after uncomplicated cataract surgery in nonglaucomatous eyes - a systematic review. Acta Ophthalmol. 2019;97:545\u201357.","journal-title":"Acta Ophthalmol"},{"key":"2940_CR15","unstructured":"Secretariat on Responsible Conduct of R, Canadian Institutes of Health R, Natural S, Engineering Research Council C, Social S, Humanities Research Council of C. Tri-council policy statement : ethical conduct for research involving humans. Ottawa, Ontario: Secretariat on Responsible Conduct of Research; 2022. Available from: http:\/\/central.bac-lac.gc.ca\/.redirect?app=damspub&id=0ab0f8e2-ddb4-4330-8498-8e235944dfc2. https:\/\/publications.gc.ca\/collections\/collection_2023\/irsc-cihr\/RR4-2-2023-eng.pdf. https:\/\/ethics.gc.ca\/eng\/policy-politique_tcps2-eptc2_2022.html."},{"key":"2940_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2940_CR17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"2940_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"2940_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0886-3350(13)80106-X","volume":"18","author":"A Wedrich","year":"1992","unstructured":"Wedrich A, Menapace R. Intraocular pressure following small-incision cataract surgery and polyHEMA posterior chamber lens implantation. A comparison between acetylcholine and carbachol. J Cataract Refract Surg. 1992;18:500\u20135.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3129\/i08-150","volume":"43","author":"M Unal","year":"2008","unstructured":"Unal M, Yucel I. Effect of bimatoprost on intraocular pressure after cataract surgery. Can J Ophthalmol. 2008;43:712\u20136.","journal-title":"Can J Ophthalmol"},{"key":"2940_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1089\/jop.2012.0244","volume":"29","author":"F Ulas","year":"2013","unstructured":"Ulas F, Balbaba M, Celebi S. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery. J Ocul Pharm Ther. 2013;29:658\u201362.","journal-title":"J Ocul Pharm Ther"},{"key":"2940_CR22","first-page":"945","volume":"8","author":"A Turk","year":"2015","unstructured":"Turk A, Ceylan OM, Gokce G, Borazan M, Kola M. Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsi fi cation. Int J Ophthalmol. 2015;8:945\u20139.","journal-title":"Int J Ophthalmol"},{"key":"2940_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0002-9394(99)80232-3","volume":"125","author":"KD Solomon","year":"1998","unstructured":"Solomon KD, Stewart WC, Hunt HH, Stewart JA, Cate EA. Intraoperative intracameral carbachol in phacoemulsification and posterior chamber lens implantation. Am J Ophthalmol. 1998;125:36\u201343.","journal-title":"Am J Ophthalmol"},{"key":"2940_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000095860","volume":"220","author":"G Scuderi","year":"2006","unstructured":"Scuderi G, Regine F, Perdicchi A, Mannino G, Recupero SM. Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification. Ophthalmologica. 2006;220:356\u201360.","journal-title":"Ophthalmologica"},{"key":"2940_CR25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0886-3350(99)00260-6","volume":"25","author":"G Rainer","year":"1999","unstructured":"Rainer G, Menapace R, Schmetterer K, Findl O, Georgopoulos M, Vass C. Effect of dorzolamide and latanoprost on intraocular pressure after small incision cataract surgery. J Cataract Refract Surg. 1999;25:1624\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR26","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S0886-3350(02)01981-8","volume":"29","author":"G Rainer","year":"2003","unstructured":"Rainer G, Menapace R, Findl O, Sacu S, Schmid K, Petternel V, et al. Effect of a fixed dorzolamide-timolol combination on intraocular pressure after small-incision cataract surgery with Viscoat. J Cataract Refract Surg. 2003;29:1748\u201352.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jcrs.2010.08.046","volume":"37","author":"N Pharmakakis","year":"2011","unstructured":"Pharmakakis N, Giannopoulos K, Stasinos S, Makri OE, Georgakopoulos CD. Effect of a fixed brimonidine-timolol combination on intraocular pressure after phacoemulsification. J Cataract Refract Surg. 2011;37:279\u201383.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/ICL.0b013e3180587e0a","volume":"34","author":"Y Ozkurt","year":"2008","unstructured":"Ozkurt Y, Oral Y, Karacan O, Comez A, Dogan OK. Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery. Eye Contact Lens. 2008;34:21\u20133.","journal-title":"Eye Contact Lens"},{"key":"2940_CR29","first-page":"851","volume":"6","author":"K Ornek","year":"2013","unstructured":"Ornek K, Buyuktortop N, Ornek N, Ogurel R, Erbahceci IE, Onaran Z. Effect of 1% brinzolamide and 0.5% timolol fixed combination on intraocular pressure after cataract surgery with phacoemulsification. Int J Ophthalmol. 2013;6:851\u20134.","journal-title":"Int J Ophthalmol"},{"key":"2940_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3928\/1542-8877-20051101-05","volume":"36","author":"S Onal","year":"2005","unstructured":"Onal S, Gozum N, Gucukoglu A. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification. Ophthalmic Surg Lasers Imaging. 2005;36:457\u201362.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2940_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0886-3350(00)00729-X","volume":"27","author":"JS Lai","year":"2001","unstructured":"Lai JS, Chua JK, Loo A, Ho SY, Lam DS. Effect of intracameral acetylcholine on latanoprost in preventing ocular hypertension after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg. 2001;27:700\u20135.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0886-3350(99)00364-8","volume":"26","author":"JS Lai","year":"2000","unstructured":"Lai JS, Chua JK, Leung AT, Lam DS. Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. J Cataract Refract Surg. 2000;26:386\u201391.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/112067210701700106","volume":"17","author":"AG Kocak-Altintas","year":"2007","unstructured":"Kocak-Altintas AG, Anayol MA, Cakmak HB, Simsek S. Effects of topical dorzolamide on IOP after phacoemulsification with different types of ophthalmic viscosurgical devices. Eur J Ophthalmol. 2007;17:38\u201344.","journal-title":"Eur J Ophthalmol"},{"key":"2940_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3129\/i08-130","volume":"43","author":"E Kir","year":"2008","unstructured":"Kir E, Cakmak H, Dayanir V. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification. Can J Ophthalmol. 2008;43:559\u201362.","journal-title":"Can J Ophthalmol"},{"key":"2940_CR35","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/S0886-3350(02)01454-2","volume":"28","author":"SR Kasetti","year":"2002","unstructured":"Kasetti SR, Desai SP, Sivakumar S, Sunderraj P. Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine. J Cataract Refract Surg. 2002;28:2177\u201380.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/ceo.12092","volume":"41","author":"CD Georgakopoulos","year":"2013","unstructured":"Georgakopoulos CD, Makri OE, Plotas P, Pharmakakis N. Brinzolamide-timolol fixed combination for the prevention of intraocular pressure elevation after phacoemulsification. Clin Exp Ophthalmol. 2013;41:662\u20137.","journal-title":"Clin Exp Ophthalmol"},{"key":"2940_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1120672118817997","volume":"30","author":"CD Georgakopoulos","year":"2020","unstructured":"Georgakopoulos CD, Kagkelaris K, Pagoulatos D, Plotas P, Makri OE. Brinzolamide-brimonidine fixed combination for the prevention of intraocular pressure elevation after phacoemulsification. Eur J Ophthalmol. 2020;30:293\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"2940_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.eye.6701470","volume":"19","author":"SS Ermis","year":"2005","unstructured":"Ermis SS, Ozturk F, Inan UU. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification. Eye. 2005;19:303\u20137.","journal-title":"Eye"},{"key":"2940_CR39","first-page":"190","volume":"4","author":"H Erdogan","year":"2011","unstructured":"Erdogan H, Ozec AV, Caner C, Toker MI, Arici MK, Topalkara A. Effect of latanoprost\/timolol and dorzolamide\/tiomolol on intraocular pressure after phacoemulsification surgery. Int J Ophthalmol. 2011;4:190\u20134.","journal-title":"Int J Ophthalmol"},{"key":"2940_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jcrs.2004.07.024","volume":"31","author":"V Dayanir","year":"2005","unstructured":"Dayanir V, Ozcura F, Kir E, Topaloglu A, Ozkan SB, Aktunc T. Medical control of intraocular pressure after phacoemulsification. J Cataract Refract Surg. 2005;31:484\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR41","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.jcrs.2003.12.050","volume":"30","author":"A Cetinkaya","year":"2004","unstructured":"Cetinkaya A, Akman A, Akova YA. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification. J Cataract Refract Surg. 2004;30:1736\u201341.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/eye.1999.52","volume":"13","author":"O Cekic","year":"1999","unstructured":"Cekic O, Batman C. Effect of intracameral carbachol on intraocular pressure following clear corneal phacoemulsification. Eye. 1999;13:209\u201311.","journal-title":"Eye"},{"key":"2940_CR43","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jcrs.2007.06.046","volume":"33","author":"M Borazan","year":"2007","unstructured":"Borazan M, Karalezli A, Akman A, Akova YA. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat. J Cataract Refract Surg. 2007;33:1941\u20135.","journal-title":"J Cataract Refract Surg"},{"key":"2940_CR44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/bjo.79.9.809","volume":"79","author":"TG Bomer","year":"1995","unstructured":"Bomer TG, Lagreze WD, Funk J. Intraocular pressure rise after phacoemulsification with posterior chamber lens implantation: effect of prophylactic medication, wound closure, and surgeon\u2019s experience. Br J Ophthalmol. 1995;79:809\u201313.","journal-title":"Br J Ophthalmol"},{"key":"2940_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/jop.2006.22.34","volume":"22","author":"MK Arici","year":"2006","unstructured":"Arici MK, Erdogan H, Toker I, Vural A, Topalkara A. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery. J Ocul Pharm Ther. 2006;22:34\u201340.","journal-title":"J Ocul Pharm Ther"},{"key":"2940_CR46","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s10384-004-0116-5","volume":"48","author":"H Erdogan","year":"2004","unstructured":"Erdogan H, Toker MI, Arici MK, Topalkara A. Effect of latanoprost 0.005% and brimonidine 0.2% on intraocular pressure after phacoemulsification and intraocular lens implantation surgery. Jpn J Ophthalmol. 2004;48:600\u20131.","journal-title":"Jpn J Ophthalmol"},{"key":"2940_CR47","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/bjo.82.11.1249","volume":"82","author":"J Hutzelmann","year":"1998","unstructured":"Hutzelmann J, Owens S, Shedden A, Adamsons I, Vargas E. Comparison of the safety and efficacy of the fixed combination of dorzolamide\/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group. Br J Ophthalmol. 1998;82:1249\u201353.","journal-title":"Br J Ophthalmol"},{"key":"2940_CR48","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/112067210501500508","volume":"15","author":"FJ Goni","year":"2005","unstructured":"Goni FJ, Brimonidine\/Timolol Fixed Combination Study G. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension. Eur J Ophthalmol. 2005;15:581\u201390.","journal-title":"Eur J Ophthalmol"},{"key":"2940_CR49","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/0002-9394(83)90388-4","volume":"95","author":"FG Berson","year":"1983","unstructured":"Berson FG, Patterson MM, Epstein DL. Obstruction of aqueous outflow by sodium hyaluronate in enucleated human eyes. Am J Ophthalmol. 1983;95:668\u201372.","journal-title":"Am J Ophthalmol"},{"key":"2940_CR50","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0161-6420(95)30869-X","volume":"102","author":"LF Rosenberg","year":"1995","unstructured":"Rosenberg LF, Krupin T, Ruderman J, McDaniel DL, Siegfried C, Karalekas DP, et al. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise. Ophthalmology. 1995;102:1312\u20138.","journal-title":"Ophthalmology"},{"key":"2940_CR51","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/OPTH.S3840","volume":"2","author":"AJ Lee","year":"2008","unstructured":"Lee AJ, McCluskey P. Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure. Clin Ophthalmol. 2008;2:545\u201355.","journal-title":"Clin Ophthalmol"},{"key":"2940_CR52","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1517\/14656560903300103","volume":"10","author":"C Costagliola","year":"2009","unstructured":"Costagliola C, dell\u2019Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F. Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics. Expert Opin Pharmacother. 2009;10:2663\u201377.","journal-title":"Expert Opin Pharmacother"},{"key":"2940_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.exer.2003.09.021","volume":"78","author":"MM Civan","year":"2004","unstructured":"Civan MM, Macknight AD. The ins and outs of aqueous humour secretion. Exp Eye Res. 2004;78:625\u201331.","journal-title":"Exp Eye Res"},{"key":"2940_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","volume":"19","author":"MF Sugrue","year":"2000","unstructured":"Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Retin Eye Res. 2000;19:87\u2013112.","journal-title":"Prog Retin Eye Res"},{"key":"2940_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/00365510601034736","volume":"67","author":"T Nieminen","year":"2007","unstructured":"Nieminen T, Lehtimaki T, Maenpaa J, Ropo A, Uusitalo H, Kahonen M. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest. 2007;67:237\u201345.","journal-title":"Scand J Clin Lab Invest"},{"key":"2940_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ophtha.2005.10.045","volume":"113","author":"N Orzalesi","year":"2006","unstructured":"Orzalesi N, Rossetti L, Bottoli A, Fogagnolo P. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology. 2006;113:239\u201346.","journal-title":"Ophthalmology"},{"key":"2940_CR57","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s003470170040","volume":"98","author":"O Schwenn","year":"2001","unstructured":"Schwenn O, Xia N, Krummenauer F, Dick HB. [Prevention of early postoperative increase in intraocular pressure after phacoemulsification. Comparison of different antiglaucoma drugs]. Ophthalmologe 2001;98:934\u201343.","journal-title":"Ophthalmologe"},{"key":"2940_CR58","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2016.09.027","volume":"124","author":"RJ Olson","year":"2017","unstructured":"Olson RJ, Braga-Mele R, Chen SH, Miller KM, Pineda R 2nd, Tweeten JP, et al. Cataract in the Adult Eye Preferred Practice Pattern(R). Ophthalmology. 2017;124:P1\u2013P119.","journal-title":"Ophthalmology"},{"key":"2940_CR59","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3129\/i08-133","volume":"43","author":"Canadian Ophthalmological Society Cataract Surgery Clinical Practice Guideline Expert C.","year":"2008","unstructured":"Canadian Ophthalmological Society Cataract Surgery Clinical Practice Guideline Expert C. Canadian Ophthalmological Society evidence-based clinical practice guidelines for cataract surgery in the adult eye. Can J Ophthalmol. 2008;43:S7\u201357.","journal-title":"Can J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02940-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T17:06:30Z","timestamp":1716570390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2940"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-02940-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed by the McGill University\u2019s Faculty of Medicine Institutional Review Board and was exempt from ethics review based on article 2.2(b) of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. The study adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}